Skip to main content

Table 2 Results of the univariable Cox regression analysis. For variables with missing values, only known values were considered for model building

From: Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

Variable

HR

95% CI

p

lower

higher

RT-protocol NFRT vs HFRT

1.381

0.906

2.106

0.133

Age (continuous)

1.023

1.007

1.039

0.0052

Gender: Female vs. Male

0.700

0.481

1.019

0.062

Surgery extent:

Subtotal vs. complete resection

1.253

0.797

1.969

0.329

Debulking vs. complete resection

1.152

0.557

2.385

0.703

Biopsy vs. complete resection

2.813

1.752

4.516

1.87 × 10−5

Mental status: Impaired vs. Normal

0.809

0.421

1.554

0.524

Neurological function: Impaired vs. Normal

1.008

0.671

1.514

0.969

MGMT methylation: Yes vs. No

0.232

0.133

0.403

2.23 × 10−7

IDH mutation: Yes vs. No

0.167

0.023

1.211

0.0766

Secondary GBM: Yes vs. No

0.311

0.143

0.676

0.0032

PTV: >  269 ccm vs. ≤269 ccm

1.750

1.168

2.622

0.00668

Temozolomide: Yes vs. No

0.523

0.355

0.769

0.000984

Steroids: Yes vs. No

2.205

1.471

3.307

0.00013

Salvage: Yes vs. No

0.268

0.180

0.400

1.24 × 10−10

KPS:

70–80 vs. < 70

90–100 vs. < 70

0.786

0.706

0.426

0.386

1.447

1.292

0.440

0.259

Treatment period:

2008–2013 vs. 2004-2008

3.591

1.117

11.55

0.032

2014–2018 vs. 2004-2008

3.662

1.119

11.98

0.032

Tumor treating fields: Yes vs. No

0.836

0.386

1.809

0.649

  1. 0.005 P value entries are in bold